STIM > massive volume on today's news! 4.28 > Neuronetics Gets Another FDA Clearance For Transcranial Magnetic Stimulation System; Shares Jump 22% -- MarketWatch 8:57 am ET July 19, 2022 (MarketWatch) Print Shares of Neuronetics Inc. (STIM) gained 22.5% in premarket trading on Tuesday after the company said it received clearance from the Food and Drug Administration to market its transcranial magnetic stimulation system as a treatment for anxiety in adults with major depressive disorder. The system was previously cleared to treat obsessive-compulsive disorder. Neuronetics' stock is down 18.4% this year, while the broader S&P 500 has declined 18.9%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.